ImageneBio, Inc. Operating Lease Right-of-Use Assets
ImageneBio, Inc. (IMA) had Operating Lease Right-of-Use Assets of $521.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-05
- 2026-06-30: Operating Lease, Right-of-Use Asset $521.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $616.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $790.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $884.00K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $521.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $616.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $790.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $884.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.56M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $3.10M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $547.00K 10-K · filed 2026-03-10 | $3.63M 10-K · filed 2025-03-06 |
| 2024-09-30 | $4.16M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $4.78M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $5.24M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $5.69M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $7.99M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.58M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $4.92M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $5.25M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $5.58M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $5.91M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $6.23M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $6.54M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $6.84M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $7.14M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $7.44M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $170.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |